These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 15374950

  • 1. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
    Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M.
    Cancer Res; 2004 Sep 15; 64(18):6424-31. PubMed ID: 15374950
    [Abstract] [Full Text] [Related]

  • 2. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
    Iida K, Itoh K, Maher JM, Kumagai Y, Oyasu R, Mori Y, Shimazui T, Akaza H, Yamamoto M.
    Carcinogenesis; 2007 Nov 15; 28(11):2398-403. PubMed ID: 17602169
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.
    Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW.
    Proc Natl Acad Sci U S A; 2001 Mar 13; 98(6):3410-5. PubMed ID: 11248092
    [Abstract] [Full Text] [Related]

  • 4. Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.
    Iida K, Mimura J, Itoh K, Ohyama C, Fujii-Kuriyama Y, Shimazui T, Akaza H, Yamamoto M.
    J Biochem; 2010 Mar 13; 147(3):353-60. PubMed ID: 19880377
    [Abstract] [Full Text] [Related]

  • 5. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
    Moon RC, Kelloff GJ, Detrisac CJ, Steele VE, Thomas CF, Sigman CC.
    Anticancer Res; 1994 Mar 13; 14(1A):5-11. PubMed ID: 8166455
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
    Kwak MK, Itoh K, Yamamoto M, Sutter TR, Kensler TW.
    Mol Med; 2001 Feb 13; 7(2):135-45. PubMed ID: 11471548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of an unintended consequence of Nrf2-directed cytoprotection against a key tobacco carcinogen plus a counteracting chemopreventive intervention.
    Paonessa JD, Ding Y, Randall KL, Munday R, Argoti D, Vouros P, Zhang Y.
    Cancer Res; 2011 Jun 01; 71(11):3904-11. PubMed ID: 21487034
    [Abstract] [Full Text] [Related]

  • 11. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
    Kwak MK, Egner PA, Dolan PM, Ramos-Gomez M, Groopman JD, Itoh K, Yamamoto M, Kensler TW.
    Mutat Res; 2001 Sep 01; 480-481():305-15. PubMed ID: 11506823
    [Abstract] [Full Text] [Related]

  • 12. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Miyazawa K, Miyamoto S, Suzuki R, Yasui Y, Ikeda R, Kohno H, Yano M, Tanaka T, Hata K, Suzuki K.
    Oncol Rep; 2007 Feb 01; 17(2):297-304. PubMed ID: 17203164
    [Abstract] [Full Text] [Related]

  • 13. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Sugie S, Vinh PQ, Rahman KM, Ushida J, Kohno H, Suzuki R, Hara A, Quang le B, Tanaka T, Mori H.
    Int J Cancer; 2005 Nov 20; 117(4):524-30. PubMed ID: 15929075
    [Abstract] [Full Text] [Related]

  • 14. Chemoprevention by inducers of carcinogen detoxication enzymes.
    Kensler TW.
    Environ Health Perspect; 1997 Jun 20; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
    Ko MS, Lee SJ, Kim JW, Lim JW, Kim SG.
    Drug Metab Dispos; 2006 Aug 20; 34(8):1353-60. PubMed ID: 16714377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
    Grubbs CJ, Juliana MM, Eto I, Casebolt T, Whitaker LM, Canfield GJ, Manczak M, Steele VE, Kelloff GJ.
    Anticancer Res; 1993 Aug 20; 13(1):33-6. PubMed ID: 8476227
    [Abstract] [Full Text] [Related]

  • 20. Induction of a rat liver benzo[a]pyrene-trans-7,8-dihydrodiol glucuronidating activity by oltipraz and beta-naphthoflavone.
    Kessler FK, Ritter JK.
    Carcinogenesis; 1997 Jan 20; 18(1):107-14. PubMed ID: 9054596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.